Risedronate and pyrexia Patient Reports February 12, 2012

Risedronate Side Effects Report #5599754-0
Risedronate side effect was reported by a Physician from JAPAN on Jan 04, 2008. Male patient, 83 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: joint dislocation, malaise, osteonecrosis , pyrexia. Risedronate dosage: 2.5 MG, DAILY, ORAL. During the same period patient was treated with AMLODIPINE BESYLATE, ALESION, AZUCURENIN S, BICARBONATE IN PLASTIC CONTAINER, MOBIC, FAMOTIDINE, ATINES, PREDNISONE. Patient was hospitalized. Patient recovered.

Risedronate Side Effects Report #5401425-8
Risedronate side effect was reported by a Physician from JAPAN on July 12, 2007. Female patient, 81 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: blood pressure decreased, dizziness , headache , nausea , pyrexia, shock, sudden hearing loss, tinnitus . Risedronate dosage: 17.5 MG, 1/WEEK, ORAL. During the same period patient was treated with LANSOPRAZOLE, NORVASC, ASPIRIN, ENALAPRIL MALEATE, GOSYAZINKIGAN, MUCOSTA, DEPAS. Patient was hospitalized. Patient recovered.

Risedronate Side Effects Report #5673967-1
Risedronate side effect was reported by a Physician from JAPAN on Mar 04, 2008. Female patient, 69 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: fracture , osteomyelitis, osteonecrosis , pain , pyrexia, swelling face, tooth extraction. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with DIAZEPAM, LIPOVAS, ISOSORBIDE DINITRATE, MAGMITT, ZOLPIDEM TARTRATE, NORVASC, METHYCOBAL, ASPIRIN. Patient was hospitalized. Patient recovered.

Risedronate Side Effects Report #4738022-3
Risedronate side effect was reported by a Consumer or non-health professional from JAPAN on July 22, 2005. Female patient, 66 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: cough, cryptogenic organizing pneumonia, pleural effusion, pneumonitis, pulmonary fibrosis , pyrexia. Risedronate dosage: unknown. During the same period patient was treated with PRAVASTATIN, NEUROTROPIN, MENATETRENONE, SAIREI. Patient recovered.


Risedronate Side Effects Report #5485937-7
Risedronate side effect was reported by a Physician from JAPAN on Sept 27, 2007. Male patient, 60 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, c-reactive protein increased, leukopenia, platelet count decreased, pyrexia, red blood cell count decreased. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with PREDNISONE, LORFENAMIN, MUCOSTA, SULFAMETHOXAZOLE, VITAMEDIN. Patient was hospitalized. Patient recovered.

Risedronate Side Effects Report #5780266-6
Risedronate side effect was reported by a Physician from AUSTRALIA on June 20, 2008. Male patient, weighting 197.5 lb, was diagnosed with osteitis deformans, type 2 diabetes mellitus and was treated with Risedronate. After drug was administered, patient experienced the following side effects: bronchitis , chills, cough, dyspnoea, escherichia infection, lethargy, pneumonia , pyrexia. Risedronate dosage: 30MG. During the same period patient was treated with METFORMIN. Patient was hospitalized. Patient recovered.

Risedronate Side Effects Report #5094337-3
Risedronate side effect was reported by a Physician from JAPAN on Aug 10, 2006. Female patient, 61 years of age, was diagnosed with reflux oesophagitis, arthralgia and was treated with Risedronate. After drug was administered, patient experienced the following side effects: agranulocytosis, arthralgia, back pain , neutropenia, neutrophil percentage increased, non-hodgkin's lymphoma, pyrexia, reflux oesophagitis, white blood cell count decreased. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with LANSOPRAZOLE, OSTELUC, PREDNISOLONE, RITUXAN, CYCLOPHOSPHAMIDE, DOXORUBICIN, ONCOVIN. Patient was hospitalized. Patient recovered.